Pronium
Natural health product licensed in Canada
- Licence holder
- Eclavis Healthcare Inc.
- NPN or DIN-HM
- 80139527
- Status
- Active licence
- Licence date
- 25 March 2025
- Revision date
- 1 December 2025
- Form
- Sirop
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pelargonium sidoides Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 200 mg | 20 mg | Not calculated |
| Propolis Source : Apis mellifera - sécrétion | 45 mg | Not calculated |
Non-medicinal ingredients
Glycérine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 5 mL | 3 Tous les jours |
| Adolescentes | minimum: 13 years ; maximum: 17 years | 5 mL | 3 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | 5 mL | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Clinically proven to) provide(s) symptomatic relief from/reduce(s) symptom severity of bronchitis, laryngitis, pharyngitis, and/or the common cold. (Clinically proven to) relieve(s) symptoms (of cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with bronchitis, laryngitis, pharyngitis, and/or the common cold. Helps to reduce the recovery time from/duration of bronchitis, laryngitis, pharyngitis, and/or the common cold. Helps shorten the duration and reduce symptom severity (such as sore throat) of the common cold, bronchitis, laryngitis and pharyngitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80139527
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.